Schizoaffective Disorder, Schizophrenia
Conditions
Keywords
schizophrenia, Schizoaffective Disorder, disease management, treatment, rehabilitation, pharmacotherapy
Brief summary
Schizophrenia is a chronic debilitating mental disorder, characterised by a relapsing remitting course. Although anti-psychotics can prevent relapse, its effect on schizophrenia outcome remains very limited, mainly due to very poor adherence to medications by the patients. This study aims to find, whether the add-on of remote monitoring of medication compliance via tele-medicine, to routine out-patient clinic care, can improve patients adherence and reduce the risk of relapse.
Detailed description
Schizophrenia is a chronic debilitating mental disorder, characterised by a relapsing remitting course. Although anti-psychotics can prevent relapse, its effect on schizophrenia outcome remains very limited, mainly due to very poor adherence to medications by the patients. This study aims to find, whether the add-on of remote monitoring of medication compliance via tele-medicine, to routine out-patient clinic care, can improve patients adherence and reduce the risk of relapse. The study is an uni center, open, prospective, randomised and controlled.
Interventions
OTHERTele-medicine monitoring of medication adherence
Sponsors
SHL Telemedicine Ltd.
Shalvata Mental Health Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* DSM 4 diagnosis of schizophrenia or schizoaffective * able to give written informed consent * Have a telephone line
Exclusion criteria
* Are not discharged to a place with routine medication monitoring * Are not discharged under forced ambulatory treatment order * Are not homeless * Are not admitted due to drug intoxication or withdrawal. * Are not admitted due to severe self harm.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to re-hospitalisation | 1 year | Time to re-hospitalisation will be compared in the study group and in the control group during the follow-up period of up to one year |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| number of re-hospitalisations | 1 year | number of re-hospitalisations will be compared among the study and the control groups during the 1 year follow-up. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Total time in hospital | 1 year | Total time in hospital during the 1 year follow-up period will be compared between the study and the control groups. |
Countries
Israel
Contacts
Primary ContactIsrael Krieger, Dr. Med
Outcome results
None listed